Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Anne-Sophie

Anne-Sophie Beignon, Paris FR

Patent application numberDescriptionPublished
20100297168LENTIVIRAL GENE TRANSFER VECTORS AND THEIR MEDICINAL APPLICATIONS - The present invention relates to the design of gene transfer vectors and especially provides lentiviral gene transfer vectors suitable for either a unique administration or, for iterative administration in a host, and to their medicinal application (such as vaccination against Immunodeficiency Virus, especially suitable in human hosts). Gene transfer vectors are either integrative or non-integrative (NI) vectors, dependently upon the purpose of their use. The invention relates to the use of gene transfer vectors for unique or for multiple in vivo administration into a host in need thereof. The field of application of the present application concerns in particular animal treatment or treatment of human being (e.g. prophylactic or therapeutic or symptomatic or curative treatment), gene therapy or vaccination in vivo. These vectors may be used to elicit an immune response to prevent or to treat a pathogenic state, including virus infections (for example treatment or prevention against Immunodeficiency Virus and especially against AIDS), parasite and bacterial infections or cancers, and preferably to elicit a protective, long-lasting immune response.11-25-2010
20120315296LENTIVIRAL GENE TRANSFER VECTORS AND THEIR MEDICINAL APPLICATIONS - The present invention relates to the design of gene transfer vectors and especially provides lentiviral gene transfer vectors suitable for either a unique administration or for iterative administration in a host, and to their medicinal application (such as vaccination against Immunodeficiency Virus, especially suitable in human hosts). Gene transfer vectors can be either integrative or non-integrative vectors. The invention encompasses prophylactic, therapeutic, symptomatic, and curative treatments of animals, including humans, as well as gene therapy and vaccination in vivo.12-13-2012

Anne-Sophie Brillouet, Lawrenceville, NJ US

Patent application numberDescriptionPublished
20110251273 COMPOSITION AND METHOD OF TREATING SKIN CONDITIONS - This invention relates to compositions containing a retinoid and use of the compositions for treating skin conditions.10-13-2011

Anne-Sophie Brillouet, Louviers FR

Patent application numberDescriptionPublished
20100322883STABILIZED COMPOSITIONS CONTAINING RETINOIDS AND METAL OXIDE PIGMENTS - The present invention relates to a composition including (i) at least one retinoid and (ii) at least one pigment containing metal oxide, wherein the composition further includes at least one percent, by weight, of at least one tocopherol selected from the group consisting of alpha-tocopherol, beta-tocopherol, delta-tocopherol, gamma-tocopherol, or a mixture thereof.12-23-2010

Patent applications by Anne-Sophie Brillouet, Louviers FR

Anne-Sophie Bureau-Bayart, Bachy FR

Patent application numberDescriptionPublished
20120325361EXPANSIBLE THREADED JOINT AND METHOD FOR MAKING SAME - An expandable threaded connection includes: first and second tubular components including respective male and female ends including respective first and second and third and fourth threaded zones, insertion regions, first and second annular tongues, prominent abutment faces, and first and second concavities; the first and second tongues are respectively engaged in the second and first concavities in a made up condition, the abutment face of at least one tongue in contact with at least one concavity; the male end including a first surface between the first threaded zone and the first tongue, and the female end including a second surface between the third threaded zone and the second concavity; in the made up condition, the first and second surfaces define an annular space include large and small radial dimension zones which, after expansion, can form a metal-metal contact seal, the first tongue bearing on the second tongue.12-27-2012

Anne-Sophie Chazel, Le Plessis-Robinson FR

Patent application numberDescriptionPublished
20110222426METHOD FOR ROUTING DATA BETWEEN AT LEAST ONE GUIDED VEHICLE AND A GROUND NETWORK - A method for routing data between at least one guided vehicle and a ground network, wherein said vehicle moves on a track between at least a first and a second communication terminal arranged on the ground along the track. The terminals are capable of exchanging data streams between a ground network and at least one routing module onboard the vehicle. A transmission quality measurement for a first signal between the first terminal and the routing module is carried out periodically, a transmission quality measurement for a second signal between the second terminal and the routing module is carried out periodically, a measurement of the available data flow rate for the first signal between the ground network and the routing module is carried out periodically, a measurement of the available data flow rate for the second signal between the ground network and the routing module is carried out periodically, a routing path for at least a portion of the data between the ground network and the routing module is also periodically determined via at least one of the communication terminals if it has a measured signal quality higher than a predetermined threshold and a data flow rate higher than a predetermined threshold.09-15-2011

Anne-Sophie Cleguer, La Roche-Sur-Foron FR

Patent application numberDescriptionPublished
20120090242METHOD FOR OPERATING AN ACTUATOR FOR MANOEUVRING A WINDABLE MOBILE ELEMENT OF A HOME AUTOMATION APPLIANCE AND ACTUATOR OPERATING ACCORDING TO THIS METHOD - Method for operating an actuator for manoeuvring a windable mobile element of a home automation appliance, the mobile element being able to be displaced between two extreme positions, the method comprising a first step for definition of a first angular speed setpoint of the actuator in a first docking area and a second step for definition of a second angular speed setpoint of the actuator in a second docking area, the first and second angular speed setpoints being different.04-19-2012

Anne-Sophie Daviaud, Saint Genis Laval FR

Patent application numberDescriptionPublished
20090291137Solid oral form provided with a double release profile - The present invention relates to a solid form, intended for the administration by oral route of at least one active ingredient and capable of guaranteeing a double release mechanism of said active ingredient, the first being determined by time and the second being determined by the pH, characterized in that said active ingredient is present there in the form of a microparticle system the microparticles of which possess a core formed wholly or partly by said active ingredient and coated with at least one layer determining said release profile of said active ingredient and formed by a material composed at least (i) 25 to 75% by weight relative to the total weight of said coating of at least one polymer A which is insoluble in the gastro-intestinal fluids, (ii) 25 to 75% by weight relative to the total weight of said coating of at least one polymer B possessing a solubilization pH value comprised within the pH range from 5 to 7, and (iii) 0 to 25% by weight relative to the total weight of said coating of at least one plasticizer, said polymers A and B being present in a polymer(s) B/polymer(s) A weight ratio at least equal to 0.2511-26-2009
20100021549Microparticle oral form useful for the modified release of nanoparticles - The present invention aims to propose novel microparticle oral forms for the modified release of active ingredient(s), in particular protein or peptide in nature. It also relates to the uses, in particular therapeutic or cosmetic, of these microparticle oral forms.01-28-2010

Anne-Sophie Daviaud-Venet, Saint-Genis-Laval FR

Patent application numberDescriptionPublished
20110091537Anti-misuse solid oral pharmaceutical form provided with a specific modified release profile - The present invention relates to a solid oral pharmaceutical form, with modified release of at least one active ingredient, containing at least microparticles containing said active ingredient and at least one viscosifying agent in a form isolated from said microparticles of active ingredient, characterized in that said microparticles possess an average diameter ranging from 100 to 600 μm, and are formed by a core containing at least said active ingredient and coated with at least one coating layer, 04-21-2011

Anne-Sophie Debrie, Lille FR

Patent application numberDescriptionPublished
20090246222Live Attenuated Bordetella Strains as a Single Dose Vaccine Against Whooping cough10-01-2009

Anne-Sophie Dumé, Montpellier FR

Patent application numberDescriptionPublished
20120020961METHODS AND COMPOSITIONS FOR LIVER CANCER THERAPY - The present disclosure provides methods of treating liver cancer and preventing liver cancer recurrence with anti-progastrin antibodies, methods of monitoring treatment efficacy of anti-progastrin therapy for liver cancer, and compositions useful therefore.01-26-2012

Anne-Sophie Duserre, Courbevoie FR

Patent application numberDescriptionPublished
20090187649Server and Method for Managing DNSSEC Requests - A domain server that comprises: means (07-23-2009

Anne-Sophie Franquet, Reims FR

Patent application numberDescriptionPublished
20090071856ERECTABLE PACKAGING PARTICULARLY FOR A BOTTLE - Erectable packaging including a bottom, first and second parallel lateral walls (03-19-2009

Anne-Sophie Lalleman, Chevreuse FR

Patent application numberDescriptionPublished
20130094627PORTABLE AND VERSATILE X-RAY OR GAMMA IMAGING DEVICE FOR NON-DESTRUCTIVE EXAMINATION OF SUSPICIOUS PACKAGES, INTEGRATING TRANSMISSION AND BACKSCATTERING IMAGING TECHNIQUES - Portable and versatile X-ray or gamma imaging device for non-destructive examination of suspicious packages, integrating transmission and backscattering imaging.04-18-2013

Anne-Sophie Lepeuple, Andresy FR

Patent application numberDescriptionPublished
20090221013METHOD FOR QUANTIFYING LIVING COLIFORM MICROORGANISMS IN A WATER SAMPLE - The invention relates to a method of rapidly quantifying living coliform microorganisms in a sample of water in which the microorganisms are put into contact with a fluorogenic substrate that is hydrolyzed in methylumbelliferone by an enzyme given off by the microorganisms. Methylumbelliferone is detected by the fluorescence that it emits, with the rate at which this fluorescence varies being measured in order to determine the concentration of coliform microorganisms in the original sample on the basis of the calculated rate of variation and a correlation plot. In characteristic manner, a preliminary treatment step is performed on the sample, in particular pre-filtering, serving to remove at least some of the particles in suspension in the water, thus making it possible to achieve quantification that is entirely comparable with the quantification given by the standardized multi-well panel method. The invention is applicable to analyzing bathing water for detecting 09-03-2009

Anne-Sophie Montcuquet, Grenoble FR

Patent application numberDescriptionPublished
20120032094PROCESSING A FLUORESCENCE IMAGE BY FACTORIZING INTO NON-NEGATIVE MATRICES - A method for locating at least one fluorescent tag in a scattering medium, wherein: a) at least one tag is introduced into the medium, b) a fluorescence image is performed by an infrared excitation of the medium along a first axis, the image including a fluorescence component due to the tag, and an auto-fluorescence component due to a medium part other than the tags, c) the image is processed by factorizing into two non-negative matrices, and d) an image of the distribution of the tag(s) is determined, without the auto-fluorescence component.02-09-2012
20120153187METHOD FOR LOCATING AN OPTICAL MARKER IN A DIFFUSING MEDIUM - A method is disclosed for locating at least one optical marker in a diffusing medium, said marker having at least one optical property different from the diffusing medium, method wherein: 06-21-2012
20120256127AUTOFLUORESCENT ORGAN PHANTOM AND ASSOCIATED METHOD OF PRODUCTION - A calibration device for instrumentation for medical imaging, also called a “phantom,” including a matrix. The calibration device includes at least one additive for simulating the autofluorescence properties of an organ or of a living tissue in the spectral band covering the red and near infrared, said additive belonging to the porphyrin class, such as protoporphyrin IX.10-11-2012

Anne-Sophie Panseri, Montanay FR

Patent application numberDescriptionPublished
20090242146MODULAR DRUM - The modular drum according to the present invention consists of a central tubular profile (10-01-2009
20110167729MODULAR MOUNT FOR HANDLING DOOR WITH FLEXIBLE SCREEN - A vertical modular mount for a handling door (07-14-2011
20120145335ANTI-DROP TRANSMISSION DEVICE FOR A SERVICE DOOR WITH A FLEXIBLE CURTAIN - An anti-fall transmission device for a handling door (06-14-2012
20120211313DEVICE FOR ELECTRICAL BRAKING OF A DRIVE SHAFT - The electrical braking device according to the present invention includes a braking element (08-23-2012
20120247692DEVICE WITH ELASTIC DEFORMATION FOR RETAINING A FLEXIBLE CURTAIN OF A VERTICALLY-OPENING GOODS-HANDLING DOOR - The vertically-opening goods-handling door includes an elastic retaining device (10-04-2012

Patent applications by Anne-Sophie Panseri, Montanay FR

Anne-Sophie Panseri, Caluire-Et-Cuire FR

Patent application numberDescriptionPublished
20090101292Device for detecting an obstacle and limiting the force of an apron in a goods-handling door - The invention relates to a device for detecting an obstacle and limiting the force from the primary edge or sill nosing (04-23-2009

Anne-Sophie Poutas, Colomiers FR

Patent application numberDescriptionPublished
20100023848METHOD AND DEVICE FOR INPUTTING DIGITAL VALUES - The invention concerns a device (01-28-2010

Anne-Sophie Saurel, Toulouse FR

Patent application numberDescriptionPublished
20090318555Treatment of Vertigo with Acetyl-L-Leucine - The use of acetyl-L-leucine and the pharmaceutically acceptable salts of same for the manufacture of a medicament for the treatment of vertigo and other balance disorders. Advantageously, the acetyl-L-leucine is a 100% mixture.12-24-2009

Anne-Sophie Stragier, Grenoble FR

Patent application numberDescriptionPublished
20120088351METHOD FOR TRANSFERRING AT LEAST ONE MICRO-TECHNOLOGICAL LAYER - A method for transferring a micro-technological layer includes preparing a substrate having a porous layer buried beneath a useful surface, forming an embrittled zone between it and the surface, bonding the substrate to a supporting substrate, causing detachment at the porous layer by mechanical stress to obtain a first substrate remnant, and a bare surfaced detached layer joined to the supporting substrate, performing technological steps on the bared surface of the detached layer, bonding the detached layer, by the surface to which the technological steps had been applied, to a second supporting substrate, causing detachment, at the embrittled zone, by heat treatment to obtain a detached layer remnant joined to the second supporting substrate, and the detached layer remnant joined to the first supporting substrate.04-12-2012

Anne-Sophie Vintimiglia, Marseille FR

Patent application numberDescriptionPublished
20090067913Cosmetic Product Distributor Applicator - The mascara distributor applicator (03-12-2009

Anne-Sophie Wavreille, Lausanne CH

Patent application numberDescriptionPublished
20120244253HYDROLYZED WHOLE GRAIN COMPOSITION - The present invention relates to a hydrolyzed whole grain composition comprising an alpha-amylase or fragments thereof, which alpha-amylase or fragments thereof show no hydrolytic activity towards dietary fibers when in the active state, and wherein the hydrolyzed whole grain composition has: (i) a glucose content of at least 0.25% by weight of the hydrolysed whole grain composition, on a dry matter basis; (ii) a maltose to glucose ratio below 144:1 by weight in the composition, (iii) a maltose to fructose ratio below 230:1 by weight in the composition or (iv) a maltose to glucose+fructose ratio below 144:1 by weight in the composition.09-27-2012
20120269928FOOD PRODUCTS AND COATINGS THEREFORE COMPRISING HYDROLYZED WHOLE GRAIN - The present invention relates to a coating mixture comprising a sweetening agent, a hydrolyzed whole grain composition, an alpha-amylase or fragment thereof, which alpha-amylase or fragment thereof shows no hydrolytic activity towards dietary fibers when in the activestate, and wherein the coating mixture has a content of sweetening agent of more than 20% by weight of the coating mixture. In addition the invention relates to cereal products comprising such coatings.10-25-2012